MX2015015681A - Pharmaceutical composition comprising fingolimod. - Google Patents

Pharmaceutical composition comprising fingolimod.

Info

Publication number
MX2015015681A
MX2015015681A MX2015015681A MX2015015681A MX2015015681A MX 2015015681 A MX2015015681 A MX 2015015681A MX 2015015681 A MX2015015681 A MX 2015015681A MX 2015015681 A MX2015015681 A MX 2015015681A MX 2015015681 A MX2015015681 A MX 2015015681A
Authority
MX
Mexico
Prior art keywords
fingolimod
pharmaceutical composition
capsules
tablets
lubricant
Prior art date
Application number
MX2015015681A
Other languages
Spanish (es)
Other versions
MX370184B (en
Inventor
Fernández Lisardo Álvarez
Van Frans Dalen
Original Assignee
Synthon Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthon Bv filed Critical Synthon Bv
Publication of MX2015015681A publication Critical patent/MX2015015681A/en
Publication of MX370184B publication Critical patent/MX370184B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to a pharmaceutical composition suitable for oral administration of fingolimod, which composition exhibits improved stability and has advantageous properties in making orally administrable final dosage forms such as capsules or tablets. The composition comprises fingolimod or a pharmaceutically acceptable salt or ester thereof, tripotassium citrate and, optionally, a lubricant.
MX2015015681A 2013-05-13 2013-10-31 Pharmaceutical composition comprising fingolimod. MX370184B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP2013059807 2013-05-13
PCT/EP2013/072767 WO2013190151A1 (en) 2013-05-13 2013-10-31 Pharmaceutical composition comprising fingolimod

Publications (2)

Publication Number Publication Date
MX2015015681A true MX2015015681A (en) 2016-03-15
MX370184B MX370184B (en) 2019-12-04

Family

ID=49517499

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015015681A MX370184B (en) 2013-05-13 2013-10-31 Pharmaceutical composition comprising fingolimod.

Country Status (3)

Country Link
ES (1) ES2770500T3 (en)
MX (1) MX370184B (en)
WO (1) WO2013190151A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016042493A1 (en) 2014-09-19 2016-03-24 Aizant Drug Research Pvt. Ltd Pharmaceutical compositions of fingolimod
EP3810274A4 (en) * 2018-06-21 2022-03-16 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi A combination comprising fingolimod and at least one anti-epileptic agent
GR1009654B (en) * 2018-08-31 2019-11-18 Φαρματεν Α.Β.Ε.Ε. Pharmaceutical composition comprising an immunomodulatory agent and method for the preparation thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE028247T2 (en) * 2003-04-08 2016-12-28 Novartis Ag Solid oral composition comprising a S1P receptor agonist and a sugar alcohol
EP2560619A2 (en) * 2010-04-22 2013-02-27 Ratiopharm GmbH A method of preparing an oral dosage form comprising fingolimod

Also Published As

Publication number Publication date
WO2013190151A1 (en) 2013-12-27
ES2770500T3 (en) 2020-07-01
MX370184B (en) 2019-12-04

Similar Documents

Publication Publication Date Title
NZ742220A (en) Pharmaceutical compositions comprising meloxicam
SG10201810985XA (en) Tofacitinib oral sustained release dosage forms
EA201690107A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING DIMETHYLFUMATE FOR INTRODUCTION TO LOW DAILY DOSE
MX351584B (en) Aqueous pharmaceutical formulation of tapentadol for oral administration.
MX2013014788A (en) Modified release of 4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]am ino]-n-5-(4-methyl-1h-imidazol-1-yl)-3-(trifluoromethyl)phenyl] benzamide solubilized using organic acids.
PH12015500823A1 (en) Modified release formulations for oprozomib
MX2015001917A (en) Pharmaceutical compositions of memantine.
IN2013MU02206A (en)
WO2014033526A9 (en) Pharmaceutical compositions of etoricoxib
WO2015125152A3 (en) Pharmaceutical compositions of asenapine
PH12015501377A1 (en) Solid unit with high fexofenadine content and process for the preparation thereof
MX2015015681A (en) Pharmaceutical composition comprising fingolimod.
WO2014125504A3 (en) Pharmaceutical compositions of febuxostat
WO2014167579A3 (en) Stable pharmaceutical compositions of tadalafil
GR1008228B (en) Pharmaceutical composition comprising a dual reuptake inhibitor and method for the preparation thereof
EA201991286A1 (en) A SOLID PHARMACEUTICAL COMPOSITION FOR ORAL USE CONTAINING TENOFOVIR AND EMTRITSITABIN
WO2014122671A3 (en) Solid oral compositions of saxagliptin
IN2014DN07898A (en)
PH12016502540A1 (en) Pharmaceutical dosage forms
WO2013054178A3 (en) Extended release pharmaceutical compositions containing carmabazepine
WO2014141298A3 (en) Stable pharmaceutical composition of fingolimod
ES2422657A1 (en) Solid cilostazol pharmaceutical composition
IN2013MU01330A (en)
MX2016004445A (en) Stable triflusal powder formulation for oral administration and method of preparation thereof.
GR1007907B (en) Pharmaceutical composition containing a phenocarbamate acetylcholinesterase inhibitor

Legal Events

Date Code Title Description
FG Grant or registration